Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gregory K. Robbins, M.D.

Co-Author

This page shows the publications co-authored by Gregory Robbins and Bruce Walker.
Connection Strength

0.746
  1. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection. PLoS One. 2007 Mar 28; 2(3):e321.
    View in: PubMed
    Score: 0.088
  2. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med. 2006 Dec; 3(12):e492.
    View in: PubMed
    Score: 0.086
  3. Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization. AIDS. 2003 May 23; 17(8):1121-6.
    View in: PubMed
    Score: 0.067
  4. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol. 2002 Dec; 76(24):12584-95.
    View in: PubMed
    Score: 0.065
  5. Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J Virol. 2002 Mar; 76(6):2817-26.
    View in: PubMed
    Score: 0.062
  6. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med. 2001 Jan 15; 193(2):169-80.
    View in: PubMed
    Score: 0.057
  7. Immune control of HIV-1 after early treatment of acute infection. Nature. 2000 Sep 28; 407(6803):523-6.
    View in: PubMed
    Score: 0.056
  8. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000 May 01; 191(9):1499-512.
    View in: PubMed
    Score: 0.054
  9. Characterization of HIV-1-specific T-helper cells in acute and chronic infection. Immunol Lett. 1999 Mar; 66(1-3):89-93.
    View in: PubMed
    Score: 0.050
  10. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7.
    View in: PubMed
    Score: 0.028
  11. Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology. 2011 Feb; 140(2):686-696.e1.
    View in: PubMed
    Score: 0.028
  12. Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection. Clin Infect Dis. 2006 Apr 01; 42(7):1024-31.
    View in: PubMed
    Score: 0.020
  13. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med. 2004 Sep 20; 200(6):701-12.
    View in: PubMed
    Score: 0.018
  14. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 2004 Sep; 127(3):924-36.
    View in: PubMed
    Score: 0.018
  15. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest. 2003 Sep; 112(6):831-42.
    View in: PubMed
    Score: 0.017
  16. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc Natl Acad Sci U S A. 2001 Feb 13; 98(4):1781-6.
    View in: PubMed
    Score: 0.014
  17. Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif. J Virol. 2001 Feb; 75(3):1301-11.
    View in: PubMed
    Score: 0.014
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.